Drug
adagrasib
1 HCP commentary report on clinical trials studying adagrasib. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| Krascendo 1 NCT06497556 · Hoffmann-La Roche | Non-small cell lung cancer | Phase 3 | 27 | 16 | Focused | Oct 18, 2026 | Preview |